Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 in Healthy Volunteers
Clinical trial NCT04868292 · COMPLETED
Trial details
- NCT number
- NCT04868292
- Sponsor
- Spero Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-03
- Primary completion
- 2021-09-16
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.